Skip to content
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
Menu
  • Pα+
Search
Join Pα+
  • Sign in
Menu
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Join Pα+
Search
Close this search box.
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Menu
  • Insights
  • Data
  • Advisory
  • Careers
  • Feed
  • Contact
  • Pα+
  • Sign in
Read more about the article Psilocybin for Depression Study Approved and Funded by German Government

Psilocybin for Depression Study Approved and Funded by German Government

  • Post published:November 19, 2020
  • Post category:Clinical Trials/News
Read more about the article Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks

Single Dose of Psilocybin Reduces Migraines for at Least 2 Weeks

  • Post published:November 14, 2020
  • Post category:Clinical Trials/Research
Read more about the article Phase 2 Clinical Trial to Evaluate Safety and Efficacy of Psilocybin in Cancer Patients with Major Depressive Disorder

Phase 2 Clinical Trial to Evaluate Safety and Efficacy of Psilocybin in Cancer Patients with Major Depressive Disorder

  • Post published:October 22, 2020
  • Post category:Clinical Trials/News
Read more about the article First Psilocybin for Depression Clinical Trial Launched in Sweden

First Psilocybin for Depression Clinical Trial Launched in Sweden

  • Post published:October 16, 2020
  • Post category:Clinical Trials/News
Read more about the article Can Taking MDMA with LSD Help Prevent a ‘Bad Trip’? New Clinical Trial Investigates

Can Taking MDMA with LSD Help Prevent a ‘Bad Trip’? New Clinical Trial Investigates

  • Post published:August 19, 2020
  • Post category:Clinical Trials/News

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

  • Insights
  • Jobs
  • Data
  • Subscribe to Pα+
  • Contact

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.

Subscribe to Pα+
  • Psychedelic Alpha © 2025, All Rights Reserved
  • Privacy Policy
  • Terms of Service

Subscribe to Our Free Newsletter

Join Pα+ for Premium Insights

Subscribe Annually ($200)
Subscribe Monthly ($20)
Learn More